![From QSR to QMSR: Meeting FDA’s New Requirements From QSR to QMSR: Meeting FDA’s New Requirements](https://www.fdanews.com/ext/resources/Book-Covers-NEW/From-QSR-to-QMSR-500.png?height=200&t=1714569011&width=200)
Home » FDA Clears Gynesonics’ Sonata System for Treating Uterine Fibroids
FDA Clears Gynesonics’ Sonata System for Treating Uterine Fibroids
August 23, 2018
The FDA granted 510(k) approval for Gynesonics’ Sonata system, a sonography-guided transcervical fibroid ablation device.
The device uses intrauterine ultrasound technology with a radiofrequency ablation device to treat uterine fibroids.
The Sonata system provides women with a transcervical treatment for uterine fibroids that requires no incisions.
Upcoming Events
-
21Oct